 |
Development of innovative nanotechnology drug delivery system for the treatment of pain (News-Medical-Net) |
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain.
More: continued here
This entry was posted on Tuesday, May 26th, 2009 and is filed under NANOTECHNOLOGY. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Leave a comment